Evaluation of Risk Factors for Malignancy Obtained by Means of Fine Needle Aspiration Biopsies in Thyroid Nodules and Surgical Outcomes of Patients with Bethesda Category III (AUS/FLUS)

被引:1
|
作者
Kimiloglu, Elife [1 ]
Ozdemir, Muhammed [2 ]
Cobanoglu, Pelin [1 ]
Kavuncu, Beyza [3 ]
Gonullu, Dogan [4 ]
机构
[1] Hlth Univ, Gaziosmanpasa Training & Res Hosp, Dept Pathol, Istanbul, Turkiye
[2] Siverek State Hosp, Minist Hlth, Siverek, Sanliurfa, Turkiye
[3] Mediwell Clin, 1A Lawsdone Rd, London N17 OLL, England
[4] Kafkas Univ, Sch Med, Dept Gen Surg, Kars, Turkiye
关键词
atypia of undetermined significance; fine needle biopsy; nuclear atypia; microfollicular atypia; TIRADS; UNDETERMINED SIGNIFICANCE; ATYPIA/FOLLICULAR LESION; ASSOCIATION GUIDELINES; FOLLICULAR LESION; ATYPIA; MANAGEMENT; SYSTEM; CARCINOMA; CYTOLOGY;
D O I
10.21614/chirurgia.2812
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The nodules diagnosed as the "atypia of undetermined significance" category are a heterogenous group with an indeterminate risk of malignancy. This study aimed to perform a detailed cytological examination of the preparations to determine the cytomorphological criteria that may be useful to distinguish benign cases from malignant ones, correlate them with ultrasonographic findings, and compare them with the final pathological result in surgically treated patients. Methods: The preparations of patients classified as Bethesda 3 were re-evaluated; presence or absence of one of 11 parameters (hypochromasia, oval nucleus, colloid, intra-nuclear pseudoinclusions, nuclear grooving, nuclear moldering, isolated nuclear enlargement, nuclear irregularity, nuclear size, microfollicular pattern, distinct nucleoli) and correlating with surgical outcomes by adding ultrasonographic findings to statistically significant parameters. Results: Two hundred and six fine needle aspirations (FNA) procedures were classified as Bethesda 3. A total of 53 patients underwent surgery; 28 (52.8%) of them were benign, and 25 (47.1%) were malignant. Thirty-two (15.5%) accepted direct surgery; 53 patients underwent repeat FNA at 3-6 month intervals and those with malignancy and repeated Bethesda 3 interpretation were operated. One hundred twenty-one (69.5%) patients who did not undergo biopsy were invited for ultrasonographic controls at 3-6 month intervals. Among the 11 cytomorphologic parameters evaluated, 7 were found to be statistically significant (p<0.05) with malignancy. When at least 3 of these parameters were positive, the malignancy rate was 92%. Malignancy was present in 19 (61.3%) of the patients with high risk nodules (TIRADS >= 4), compared to only 6 (35.8%) of the low-risk (TIRADS <= 3); there was a significant correlation between the presence of malignancy and TIRADS score (p=0.015). The preparations that displayed nucleus atypia were closely associated with the ultrasonographically high-risk group. Conclusion: The parameters indicating nuclear atypia, presence of more than 3 cytomorphological factors, TIRADS score >= 4 were significantly associated with malignancy; nuclear atypia were closely associated with the ultrasonographically high TIRADS. No significant correlation was found between the presence of "microfollicular pattern" and malignancy.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 40 条
  • [1] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
    Ho, Allen S.
    Sarti, Evan E.
    Jain, Kunal S.
    Wang, Hangjun
    Nixon, Iain J.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    Ghossein, Ronald
    Fish, Stephanie A.
    Wong, Richard J.
    Lin, Oscar
    Morris, Luc G. T.
    THYROID, 2014, 24 (05) : 832 - 839
  • [2] Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Kuru, B.
    Atmaca, A.
    Tarim, I. A.
    Kefeli, M.
    Topgul, K.
    Yoruker, S.
    Elmali, M.
    Danaci, M.
    EJSO, 2016, 42 (01): : 87 - 93
  • [3] Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy
    Ng, Jennifer Lourdes
    Escueta, Luz Margaret
    Dampil, Oliver Allan
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2023, 38 (02): : 86 - 93
  • [4] Malignancy rate associated with Bethesda category III (AUS/FLUS) with and without repeat fine needle aspiration biopsy
    Kuru, Bekir
    Atmaca, Aysegul
    Kefeli, Mehmet
    DIAGNOSTIC CYTOPATHOLOGY, 2016, 44 (05) : 394 - 398
  • [5] Patient outcomes following surgical management of thyroid nodules classified as Bethesda category III (AUS/FLUS)
    Mulita, Francesk
    Plachouri, Maria-Kerasia
    Liolis, Elias
    Vailas, Michail
    Panagopoulos, Konstantinos
    Maroulis, Ioannis
    ENDOKRYNOLOGIA POLSKA, 2021, 72 (02) : 143 - 144
  • [6] Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS): Is There a Correct Answer?
    Heller, Keith S.
    THYROID, 2014, 24 (05) : 787 - 788
  • [7] Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience
    Koseoglu, Derya
    Ozdemir Baser, Ozden
    Cetin, Zeynep
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (10) : 1110 - 1115
  • [8] The Prediction of Malignancy Risk in Thyroid Nodules Classified as Bethesda System Category III (AUS/FLUS) and the Role of Ultrasound Finding for Prediction of Malignancy Risk
    Alshahrani, Awad S.
    Alamri, Abdulrahman S.
    Balkhoyor, Abdulrahman H.
    Mahzari, Moeber M.
    Alshieban, Saeed S.
    Majed, Pharaon M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [9] Risk of malignancy in fine-needle aspiration biopsy in patients with thyroid nodules
    Egset, Alice Viktoria
    Holm, Camilla
    Larsen, Stine Rosenkilde
    Nielsen, Susanne Holm
    Bach, Jacob
    Helweg-Larsen, Jens Peter
    Larsen, Louise Volund
    Wanscher, Jens Hojberg
    Godballe, Christian
    DANISH MEDICAL JOURNAL, 2017, 64 (02):
  • [10] Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy
    Walters, Benjamin K.
    Garrett, Samuel L.
    Aden, James K.
    Williams, Grant M.
    Butler-Garcia, Samantha L.
    Newberry, Travis R.
    Mckinlay, Alex J.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (09): : 1064 - 1068